Literature DB >> 7344105

Increased circulating platelet aggregates in thalassaemia.

P Winichagoon, S Fucharoen, P Wasi.   

Abstract

Examination for circulating platelet aggregates according to Wu and Hoak revealed increased circulating platelet aggregates in 71% of splenectomized and 35% of nonsplenectomized patients with beta (0)-thalassaemia/Hb E disease. This may be causally related to the newly observed high incidences of pulmonary artery thrombosis and hypoxaemia in splenectomized thalassaemic patients. It is recommended that anti-platelet aggregation drugs such as aspirin and/or dipyridamole are given to thalassaemic patients after splenectomy.

Entities:  

Mesh:

Year:  1981        PMID: 7344105

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  12 in total

Review 1.  β-thalassemia intermedia: a clinical perspective.

Authors:  Khaled M Musallam; Ali T Taher; Eliezer A Rachmilewitz
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

2.  Thrombin Activable Fibrinolysis Inhibitor in Beta Thalassemia.

Authors:  Aruna Chhikara; Sunita Sharma; Jagdish Chandra; Anita Nangia
Journal:  Indian J Pediatr       Date:  2016-08-03       Impact factor: 1.967

3.  Thromboelastometry profile in children with beta-thalassemia.

Authors:  Ayşe B Turhan; Özcan Bör; O Meltem Akay; Necat A Akgün
Journal:  Int J Hematol       Date:  2014-03-09       Impact factor: 2.490

4.  A case of alpha-thalassemia-2 associated with pulmonary infarction.

Authors:  Seiji Hayashi; Hiroto Matsuoka; Teruo Harano; Keiko Harano; Hiroshi Nakahara; Isao Tachibana; Hiroshi Kida; Tomio Kawasaki; Shingo Kyotani; Yoshihiro Oka; Mitsunori Sakatani; Ichiro Kawase
Journal:  Lung       Date:  2006 Jul-Aug       Impact factor: 2.584

5.  In vivo platelet activation and hyperaggregation in hemoglobin E/beta-thalassemia: a consequence of splenectomy.

Authors:  Vichai Atichartakarn; Pantep Angchaisuksiri; Katcharin Aryurachai; Suporn Chuncharunee; Ammarin Thakkinstian
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

6.  Protein C and Protein S: causative factor for developing a hemorrhagic infarct in a HbE/Beta thalassemia child.

Authors:  Sharma Vineeta; Arijit Biswas; Bijender Kumar; Renu Saxena
Journal:  Indian J Pediatr       Date:  2010-01-20       Impact factor: 1.967

Review 7.  Vascular complications after splenectomy for hematologic disorders.

Authors:  Shelley E Crary; George R Buchanan
Journal:  Blood       Date:  2009-07-27       Impact factor: 22.113

Review 8.  β-Thalassemia intermedia: a comprehensive overview and novel approaches.

Authors:  Chingiz Asadov; Zohra Alimirzoeva; Tahira Mammadova; Gunay Aliyeva; Shahla Gafarova; Jeyhun Mammadov
Journal:  Int J Hematol       Date:  2018-01-29       Impact factor: 2.490

9.  Coagulopathy in Beta-thalassemia: current understanding and future perspectives.

Authors:  M Domenica Cappellini; Khaled M Musallam; Alessia Marcon; Ali T Taher
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-12-29       Impact factor: 2.576

10.  Thalassemia and venous thromboembolism.

Authors:  Julien Succar; Khaled M Musallam; Ali T Taher
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-05-25       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.